Fu, Liang
Xiong, Juan
Wang, Haibo
Zhang, Peize
Yang, Qianting
Cai, Yi
Wang, Wenfei
Sun, Feng
Zhang, Xilin
Wang, Zhaoqin
Chen, Xinchun
Zhang, Wenhong
Deng, Guofang
Funding for this research was provided by:
Shenzhen Scientific and Technological Foundation (JCYJ20180228162112889)
Project funded by Shenzhen Third People’s Hospital (G2021023, G2022155)
Summit Plan for Foshan High-level Hospital Construction (FSSYKF-2020001005597)
2020 Foshan Science and Technology Innovation Project (2020001005597)
Guangdong Provincial Clinical Research Center for Tuberculosis (2020B1111170014, 2020B1111170014)
Shenzhen Clinical Research Center for Tuberculosis (20210617141509001, 20210617141509001)
National Natural Science Foundation of China (82070016)
Article History
Received: 30 August 2023
Accepted: 25 September 2023
First Online: 27 November 2023
Declarations
:
: The trial received ethical approval from the Institutional Review Boards of Shenzhen Third People’s Hospital (approval number 2021-015-03) and other participating sites. Participants must provide signed and dated written informed consent prior to undergoing any study-specific procedures.
: Not applicable.
: The authors declare no competing interests.